NEW YORK (GenomeWeb News) – Microchip Biotechnologies has been awarded a $625,000 grant from the US Army to develop a Universal Sample Preparation Module for automatically purifying DNA from pathogen targets.
The grant was awarded from the Army’s inaugural Commercialization Pilot Program, which is intended to assist SBIR firms that are working on phase II projects that meet high priority Army requirements in transitioning to commercial products.
MBI’s sample prep module will be designed to purify DNA from pathogen targets in complex matrices to provide samples for various downstream DoD-sponsored analytical platforms. The module, which will incorporate MBI’s Microscale On-chip Valves, will be used as a front end for a molecular diagnostics system aimed at detecting biological threat agents.